Journal of Cancer Research and Therapeutics Close
 

Figure 4: Production of GA733-2-Fc specific immunoglobulin G (a and b), immunoglobulin A (c and d) and immunoglobulin E (e and f) antibodies in sera (a, c, and e, 1:100 dilutes of sera collected at 1 week after immunization; b, d, and f, serial dilutes of sera collected at 1 week after the last immunization) from mice intraperitoneally immunized with recombinant GA733-2-Fc and GA733-2-Fc-KDEL; *P < 0.05, **P < 0.01, ***P < 0.001, between treated and control groups

Figure 4: Production of GA733-2-Fc specific immunoglobulin G (a and b), immunoglobulin A (c and d) and immunoglobulin E (e and f) antibodies in sera (a, c, and e, 1:100 dilutes of sera collected at 1 week after immunization; b, d, and f, serial dilutes of sera collected at 1 week after the last immunization) from mice intraperitoneally immunized with recombinant GA733-2-Fc and GA733-2-Fc-KDEL; *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, between treated and control groups